US FDA approval: Total Knee Study | Company Announcement - Investegate
Victrex plc announces US FDA IDE approval for Freedom® Total Knee System with Invibio PEEK-OPTIMA™ Femoral Component, a 120-patient study comparing PEEK to traditional metal components. The study builds on existing trials in Europe and India, with potential commercialization in 2025.
Reference News
US FDA approval: Total Knee Study | Company Announcement - Investegate
Victrex plc announces US FDA IDE approval for Freedom® Total Knee System with Invibio PEEK-OPTIMA™ Femoral Component, a 120-patient study comparing PEEK to traditional metal components. The study builds on existing trials in Europe and India, with potential commercialization in 2025.